1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Abnormalities, Autosome in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicholas, AP | 1 |
| Lubin, FD | 1 |
| Hallett, PJ | 1 |
| Vattem, P | 1 |
| Ravenscroft, P | 1 |
| Bezard, E | 1 |
| Zhou, S | 1 |
| Fox, SH | 1 |
| Brotchie, JM | 1 |
| Sweatt, JD | 1 |
| Standaert, DG | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Abnormalities, Autosome
| Article | Year |
|---|---|
Striatal histone modifications in models of levodopa-induced dyskinesia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylation; Animals; Chromatin; Chromosome Aberration | 2008 |